A strong attenuating in vitro effect of urolithin A on ox-LDL endothelial dysfunction was noted by Han et al. [22], which was mediated through miR-27 expression and the ERK/PPARγ pathway (extracellular signal regulated kinase/peroxisome proliferator–activated receptor gamma). The gene discussed is PPARG; the disease is endothelial dysfunction.